Cardiac Valve Diseases and Treatments
Open access
Peer reviewed
Scollr summary
What this paper is about
Key guideline updates for aortic valve disease are examined, focusing on aortic stenosis (AS) and aortic regurgitation (AR), and insights from recent registries on TAVR explantation and redo-TAVR outcomes are integrated.
Full abstract
Read the full abstract
Abstract Background The 2025 European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines for valvular heart disease represent a pivotal update, emphasizing earlier intervention for aortic stenosis (AS) and broader indications for transcatheter aortic valve replacement (TAVR). These changes are driven by randomized trial data demonstrating TAVR’s safety in lower-risk patients. However, as TAVR expands to younger cohorts, long-term durability remains a concern. Main body This narrative review examines key guideline updates for aortic valve disease, focusing on aortic stenosis (AS) and aortic regurgitation (AR), and integrates insights from recent registries (2020–2025) on TAVR explantation and redo-TAVR outcomes. Data from the EXPLANT-TAVR, EXPLANTORREDO-TAVR and FRANCE 2/FRANCE TAVI registries reveal reintervention rates of 0.3–1.7% at 8 years, with redo-TAVR offering superior short-term survival (30-day mortality 1.5–6.2%) compared to explantation (11.9–13.6%). Structural valve deterioration (SVD), leaflet thrombosis, and endocarditis predominate failure causes, underscoring the need for lifetime management strategies. Conclusion Implications include refined patient selection, enhanced imaging surveillance, and Heart Team-driven decisions to balance procedural benefits against reintervention risks.
Direct answer
What can I do from this paper page?
Use this page to scan "New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Cardiac Valve Diseases and Treatments research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Paul2026EACTS,
title = {New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes},
author = {Saptarshi Paul},
journal = {Journal of Cardiothoracic Surgery},
year = {2026},
doi = {10.1186/s13019-026-04643-3},
url = {https://doi.org/10.1186/s13019-026-04643-3}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Cardiac Valve Diseases and Treatments research papers?
Follow Cardiac Valve Diseases and Treatments research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app